N2OFF extends acquisition deadline for MitoCareX by 90 days and provides additional $250K loan

Nexentis Technologies Inc.

Amendment to Securities Purchase and Exchange Agreement extends closing deadline by 90 days to 180 days from Feb 25, 2025.
Third loan agreement provides $250,000 to MitoCareX, maturing in 6 months, with interest at Israel Tax Authority rate +3%.
Amendments to two prior $250,000 loans each extend their maturity by 180 days.
New loan guaranteed by L.I.A. Pure Capital and will be deducted from future allocation if acquisition closes.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.